Michaela Kaiserová

714 total citations
29 papers, 292 citations indexed

About

Michaela Kaiserová is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Michaela Kaiserová has authored 29 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Michaela Kaiserová's work include Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological disorders and treatments (13 papers) and Alzheimer's disease research and treatments (8 papers). Michaela Kaiserová is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (19 papers), Neurological disorders and treatments (13 papers) and Alzheimer's disease research and treatments (8 papers). Michaela Kaiserová collaborates with scholars based in Czechia, Philippines and United States. Michaela Kaiserová's co-authors include Petr Kaňovský, Kateřina Menšíková, Hana Přikrylová Vranová, David Stejskal, Pavel Otruba, Petr Hluštı́k, Jan Mareš, Miroslav Strnad, Eva Hényková and Jana Zapletalová and has published in prestigious journals such as Neurology, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Michaela Kaiserová

26 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Kaiserová Czechia 11 205 98 74 74 48 29 292
Diana A. Olszewska Ireland 8 148 0.7× 76 0.8× 71 1.0× 60 0.8× 40 0.8× 32 240
Martin Nevrlý Czechia 10 271 1.3× 101 1.0× 41 0.6× 83 1.1× 46 1.0× 28 335
Geshanthi Hondhamuni United Kingdom 7 182 0.9× 135 1.4× 98 1.3× 50 0.7× 76 1.6× 7 293
Hanneke Geut Netherlands 10 121 0.6× 83 0.8× 77 1.0× 54 0.7× 61 1.3× 13 232
John Q. Trojanowski United States 4 179 0.9× 83 0.8× 64 0.9× 91 1.2× 57 1.2× 5 259
Marshall S. Goodwin United States 7 122 0.6× 147 1.5× 99 1.3× 74 1.0× 97 2.0× 9 309
Anastasia Kuzkina Germany 12 399 1.9× 115 1.2× 71 1.0× 89 1.2× 73 1.5× 17 507
Mary Xylaki Germany 9 218 1.1× 94 1.0× 117 1.6× 104 1.4× 59 1.2× 12 338
Daniel Macías‐García Spain 8 158 0.8× 55 0.6× 67 0.9× 53 0.7× 78 1.6× 23 249
Roubina Antonelou Greece 10 229 1.1× 91 0.9× 59 0.8× 64 0.9× 59 1.2× 19 303

Countries citing papers authored by Michaela Kaiserová

Since Specialization
Citations

This map shows the geographic impact of Michaela Kaiserová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Kaiserová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Kaiserová more than expected).

Fields of papers citing papers by Michaela Kaiserová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Kaiserová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Kaiserová. The network helps show where Michaela Kaiserová may publish in the future.

Co-authorship network of co-authors of Michaela Kaiserová

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Kaiserová. A scholar is included among the top collaborators of Michaela Kaiserová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Kaiserová. Michaela Kaiserová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Havránková, Petra, Jan Roth, Václav Čapek, et al.. (2024). Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson’s Disease. Neurologia i Neurochirurgia Polska. 58(6). 586–592. 2 indexed citations
2.
Mareš, Jan, Kateřina Menšíková, Michaela Kaiserová, et al.. (2024). Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis. European journal of medical research. 29(1). 31–31. 1 indexed citations
3.
Menšíková, Kateřina, Michaela Kaiserová, Hana Přikrylová Vranová, et al.. (2023). Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross‐correlation study. Journal of Neurochemistry. 167(2). 168–182. 12 indexed citations
4.
Menšíková, Kateřina, Radoslav Matěj, Carlo Colosimo, et al.. (2022). Lewy body disease or diseases with Lewy bodies?. npj Parkinson s Disease. 8(1). 3–3. 49 indexed citations
5.
Kaiserová, Michaela, et al.. (2021). Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes. Neurodegenerative Diseases. 21(1-2). 30–35. 18 indexed citations
6.
Menšíková, Kateřina, Martin Nevrlý, Michaela Kaiserová, et al.. (2021). The current state of pharmacotherapy for extrapyramidal diseases. Neurologie pro praxi. 22(3). 183–193.
7.
Kaiserová, Michaela, Kateřina Menšíková, Lucie Tučková, Petr Hluštı́k, & Petr Kaňovský. (2021). Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome. Frontiers in Neuroscience. 15. 742042–742042. 1 indexed citations
8.
Kaiserová, Michaela, et al.. (2021). Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods. Biomedical Papers. 165(2). 103–112. 5 indexed citations
9.
Hok, Pavel, Pavel Otruba, Michaela Kaiserová, et al.. (2021). Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia. Scientific Reports. 11(1). 8322–8322. 11 indexed citations
10.
Otruba, Pavel, Martin Nevrlý, Petr Kolář, et al.. (2020). Deep Brain Stimulation Effects on Gait Pattern in Advanced Parkinson’s Disease Patients. Frontiers in Neuroscience. 14. 814–814. 8 indexed citations
11.
Menšíková, Kateřina, Radek Vodička, Radek Vrtěl, et al.. (2018). New endemic familial parkinsonism in south Moravia, Czech Republic and its genetical background. Medicine. 97(38). e12313–e12313. 4 indexed citations
12.
Kaiserová, Michaela, et al.. (2016). NBIA - neurodegeneration with brain iron accumulation. Neurologie pro praxi. 17(5). 328–332.
13.
Menšíková, Kateřina, Petr Kaňovský, Pavel Otruba, et al.. (2015). Familial, autosomal-dominant neurodegenerative parkinsonism with cognitive deterioration spanning five generations in a genetically isolated population of south-eastern Moravia, Czech Republic. Biomedical Papers. 160(1). 158–160. 3 indexed citations
14.
Kaiserová, Michaela, Hana Přikrylová Vranová, Jan Gałuszka, et al.. (2015). Orthostatic hypotension is associated with decreased cerebrospinal fluid levels of chromogranin A in early stage of Parkinson disease. Clinical Autonomic Research. 25(5). 339–342. 4 indexed citations
15.
Vranová, Hana Přikrylová, Eva Hényková, Michaela Kaiserová, et al.. (2014). Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia. Journal of the Neurological Sciences. 343(1-2). 120–124. 51 indexed citations
16.
Menšíková, Kateřina, et al.. (2014). Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study. Journal of Neural Transmission. 122(6). 835–839. 11 indexed citations
17.
Vranová, Hana Přikrylová, Eva Hényková, Michaela Kaiserová, et al.. (2013). Tau Protein, beta-Amyloid 1-42 and Clusterin CSF Levels in Differential Diagnosis of Parkinsonian Syndrome with Dementia (P04.156). Neurology. 80(7_supplement). 1 indexed citations
18.
Kaiserová, Michaela, Hana Přikrylová Vranová, David Stejskal, Kateřina Menšíková, & Petr Kaňovský. (2013). Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinson’s disease: a pilot study. Journal of Neural Transmission. 120(11). 1559–1563. 5 indexed citations
19.
Batla, Amit, María Stamelou, Kateřina Menšíková, et al.. (2013). Markedly asymmetric presentation in multiple system atrophy. Parkinsonism & Related Disorders. 19(10). 901–905. 16 indexed citations
20.
Mušová, Zuzana, Michaela Kaiserová, Eva Kriegová, et al.. (2013). A Novel Frameshift Mutation in the AFG3L2 Gene in a Patient with Spinocerebellar Ataxia. The Cerebellum. 13(3). 331–337. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana A. Olszewska Breakdown of academic impact, for papers by Martin Nevrlý Breakdown of academic impact, for papers by Geshanthi Hondhamuni Breakdown of academic impact, for papers by Hanneke Geut Breakdown of academic impact, for papers by John Q. Trojanowski Breakdown of academic impact, for papers by Marshall S. Goodwin Breakdown of academic impact, for papers by Anastasia Kuzkina Breakdown of academic impact, for papers by Mary Xylaki Breakdown of academic impact, for papers by Daniel Macías‐García Breakdown of academic impact, for papers by Roubina Antonelou
Rankless by CCL
2026